1. Home
  2. CPF vs TSHA Comparison

CPF vs TSHA Comparison

Compare CPF & TSHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPF
  • TSHA
  • Stock Information
  • Founded
  • CPF 1954
  • TSHA 2019
  • Country
  • CPF United States
  • TSHA United States
  • Employees
  • CPF N/A
  • TSHA N/A
  • Industry
  • CPF Major Banks
  • TSHA Biotechnology: Pharmaceutical Preparations
  • Sector
  • CPF Finance
  • TSHA Health Care
  • Exchange
  • CPF Nasdaq
  • TSHA Nasdaq
  • Market Cap
  • CPF 725.7M
  • TSHA 728.4M
  • IPO Year
  • CPF N/A
  • TSHA 2020
  • Fundamental
  • Price
  • CPF $26.16
  • TSHA $2.63
  • Analyst Decision
  • CPF Buy
  • TSHA Strong Buy
  • Analyst Count
  • CPF 1
  • TSHA 6
  • Target Price
  • CPF $30.00
  • TSHA $8.17
  • AVG Volume (30 Days)
  • CPF 130.7K
  • TSHA 2.6M
  • Earning Date
  • CPF 07-25-2025
  • TSHA 08-15-2025
  • Dividend Yield
  • CPF 4.05%
  • TSHA N/A
  • EPS Growth
  • CPF 6.71
  • TSHA N/A
  • EPS
  • CPF 2.24
  • TSHA N/A
  • Revenue
  • CPF $253,722,000.00
  • TSHA $7,224,000.00
  • Revenue This Year
  • CPF $0.80
  • TSHA N/A
  • Revenue Next Year
  • CPF $6.33
  • TSHA N/A
  • P/E Ratio
  • CPF $11.68
  • TSHA N/A
  • Revenue Growth
  • CPF 6.59
  • TSHA N/A
  • 52 Week Low
  • CPF $23.16
  • TSHA $1.05
  • 52 Week High
  • CPF $33.25
  • TSHA $3.31
  • Technical
  • Relative Strength Index (RSI)
  • CPF 31.04
  • TSHA 52.57
  • Support Level
  • CPF $27.05
  • TSHA $2.60
  • Resistance Level
  • CPF $28.17
  • TSHA $2.91
  • Average True Range (ATR)
  • CPF 0.65
  • TSHA 0.16
  • MACD
  • CPF -0.32
  • TSHA 0.01
  • Stochastic Oscillator
  • CPF 14.46
  • TSHA 50.88

About CPF Central Pacific Financial Corp New

Central Pacific Financial Corp operates in the financial services sector in the United States. It is a full-service commercial bank offering a broad range of banking products and services, including accepting time and demand deposits and originating loans. Bank's deposits are insured by the Federal Deposit Insurance Corporation (FDIC) up to applicable limits. The bank is not a member of the Federal Reserve System. The company's loans include commercial loans, construction loans, commercial and residential mortgage loans, and consumer loans. The company derives income from interest and fees on loans, interest on investment securities, and fees received in connection with deposits and other services.

About TSHA Taysha Gene Therapies Inc.

Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.

Share on Social Networks: